Standl E

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect? - Standl_2014_Curr.Treat.Options.Cardiovasc.Med_16_353
Author(s) : Standl E , Erbach M , Schnell O
Ref : Curr Treat Options Cardiovasc Med , 16 :353 , 2014
Abstract : Standl_2014_Curr.Treat.Options.Cardiovasc.Med_16_353
ESTHER : Standl_2014_Curr.Treat.Options.Cardiovasc.Med_16_353
PubMedSearch : Standl_2014_Curr.Treat.Options.Cardiovasc.Med_16_353
PubMedID: 25283263

Title : Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes - Ahren_2004_Diabetes.Care_27_2874
Author(s) : Ahren B , Gomis R , Standl E , Mills D , Schweizer A
Ref : Diabetes Care , 27 :2874 , 2004
Abstract : Ahren_2004_Diabetes.Care_27_2874
ESTHER : Ahren_2004_Diabetes.Care_27_2874
PubMedSearch : Ahren_2004_Diabetes.Care_27_2874
PubMedID: 15562200